oral-chicken LDLo 2188 mg/kg "Ueber die Wirkung Verschiedener Gifte Auf Vogel, Dissertation," Forchheimer, L., Pharmakologischen Institut der Universitat Wurzburg, Fed. Rep. Ger., 1931Vol. -, Pg. -, 1931.
intraarterial-guinea pig LDLo 800 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 131, Pg. 171, 1928.
intravenous-guinea pig LDLo 800 mg/kg Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 131, Pg. 171, 1928.
intraperitoneal-mouse LD50 1539 mg/kg Progress in Mutation Research. Vol. 1, Pg. 682, 1981.
intravenous-mouse LD50 500 mg/kg Acta Pharmaceutica Jugoslavica. Vol. 5, Pg. 43, 1955.
oral-mouse LD50 2500 mg/kg Arzneimittel-Forschung. Drug Research. Vol. 9, Pg. 595, 1959.
unreported-mouse LD50 2000 mg/kg British Journal of Cancer. Vol. 6, Pg. 160, 1952.
parenteral-mouse LDLo 1000 mg/kg GASTROINTESTINAL: PERITONITIS Progress Report for Contract No. PH-43-63-1132, Submitted to the National Cancer Institute by Scientific Associates, Inc. Vol. PH-43-62-483
intravenous-rabbit LDLo 2000 mg/kg "Drug Dosages in Laboratory Animals - A Handbook," Rev. ed., Barnes, C.D., and L.G. Eltherington, Berkeley, Univ. of California Press, 1973Vol. -, Pg. 272, 1973.
intramuscular-rat LD50 1400 mg/kg Zeitschrift fuer Krebsforschung und Klinische Onkologie. Vol. 84, Pg. 227, 1975.
intraperitoneal-rat LD50 1500 mg/kg Cancer Research. Vol. 26, Pg. 1448, 1966.
oral-rat LD50 1809 mg/kg Cancer Letters Vol. 57, Pg. 37, 1991.
|